Strategic Global Advisors LLC purchased a new position in HCA Healthcare Inc (NYSE:HCA) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,208 shares of the company’s stock, valued at approximately $298,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Rational Advisors LLC lifted its holdings in HCA Healthcare by 5,118.2% in the 1st quarter. Rational Advisors LLC now owns 574 shares of the company’s stock worth $75,000 after purchasing an additional 563 shares in the last quarter. Magellan Asset Management Ltd grew its position in shares of HCA Healthcare by 21.0% during the second quarter. Magellan Asset Management Ltd now owns 15,621,068 shares of the company’s stock valued at $2,111,500,000 after purchasing an additional 2,712,130 shares in the last quarter. Amundi Pioneer Asset Management Inc. grew its position in shares of HCA Healthcare by 2.3% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 1,290,505 shares of the company’s stock valued at $168,257,000 after purchasing an additional 28,925 shares in the last quarter. Ballentine Partners LLC bought a new stake in shares of HCA Healthcare in the first quarter worth about $209,000. Finally, Burney Co. increased its holdings in shares of HCA Healthcare by 2.2% in the first quarter. Burney Co. now owns 79,903 shares of the company’s stock worth $10,418,000 after purchasing an additional 1,751 shares during the last quarter. 70.38% of the stock is owned by hedge funds and other institutional investors.
Shares of NYSE:HCA traded up $0.84 during trading on Wednesday, reaching $130.94. 1,073,310 shares of the company were exchanged, compared to its average volume of 1,353,669. The firm has a market capitalization of $43.48 billion, a PE ratio of 13.40, a P/E/G ratio of 1.09 and a beta of 0.87. The business’s fifty day simple moving average is $127.10 and its 200-day simple moving average is $129.27. HCA Healthcare Inc has a 12-month low of $110.31 and a 12-month high of $147.42.
The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Tuesday, September 3rd will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.22%. The ex-dividend date of this dividend is Friday, August 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.
In other HCA Healthcare news, SVP Robert A. Waterman sold 33,786 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the transaction, the senior vice president now directly owns 279,551 shares in the company, valued at approximately $37,733,793.98. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Patricia F. Elcan bought 250 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were acquired at an average cost of $124.10 per share, for a total transaction of $31,025.00. The disclosure for this purchase can be found here. 2.70% of the stock is currently owned by corporate insiders.
A number of equities analysts recently commented on HCA shares. Bank of America raised HCA Healthcare from an “underperform” rating to a “neutral” rating and increased their price target for the company from $130.00 to $137.00 in a research note on Friday, September 6th. Zacks Investment Research downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price target for the company. in a report on Monday, May 27th. Goldman Sachs Group upgraded HCA Healthcare from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $147.00 to $160.00 in a research report on Wednesday, July 10th. Mizuho set a $153.00 price objective on HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Finally, Stephens set a $150.00 price objective on HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, August 7th. Three equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $155.29.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Further Reading: What is a Swap?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.